The article discusses curing the common cold and why a vaccine against rhinoviruses, which is a group of viruses responsible for most colds, may do more harm than good. A brief overview of scientists' attempts to develop anitcold drugs is presented, including pleconaril, which was banned by the U.S. Food and Drug Administration (FDA) for its harmful side effects. Topics include a discussion regarding the search for vaccine candidates against rhinoviruses, how the structure of the virus makes developing a vaccine difficult, and research that suggest colds may provide temporary immunity against more severe infections.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados